Peter Devilee

61.0k total citations · 5 hit papers
220 papers, 18.6k citations indexed

About

Peter Devilee is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Peter Devilee has authored 220 papers receiving a total of 18.6k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Genetics, 91 papers in Molecular Biology and 82 papers in Cancer Research. Recurrent topics in Peter Devilee's work include BRCA gene mutations in cancer (98 papers), Genetic factors in colorectal cancer (51 papers) and Cancer Genomics and Diagnostics (47 papers). Peter Devilee is often cited by papers focused on BRCA gene mutations in cancer (98 papers), Genetic factors in colorectal cancer (51 papers) and Cancer Genomics and Diagnostics (47 papers). Peter Devilee collaborates with scholars based in Netherlands, United Kingdom and United States. Peter Devilee's co-authors include Fattaneh A. Tavassoli, Cees J. Cornelisse, Jean‐Pierre Bayley, Cornelisse Cj, Peter E.M. Taschner, Bert Vogelstein, Suzanne J. Baker, Rama Modali, Nancy E. Davidson and Stephen Baylin and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Peter Devilee

217 papers receiving 18.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in the p53 gene occur in diverse human tumour types

1989 2.4k citations Peter Devilee et al. profile →
Pathology and Genetics of Tumours of the Breast and Female Genital Organs

2003 2.2k citations Fattaneh A. Tavassoli, Peter Devilee profile →
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma

2000 1.3k citations Cees J. Cornelisse, Peter Devilee et al. Science profile →
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

2015 579 citations Douglas F. Easton, Peter Devilee et al. profile →
SDH5 , a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma

2009 541 citations Huai‐Xiang Hao, Oleh Khalimonchuk et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Devilee Netherlands	63	8.1k	6.6k	6.5k	5.2k	3.6k	220	18.6k
Cees J. Cornelisse Netherlands	55	5.1k 0.6×	4.4k 0.7×	2.6k 0.4×	3.5k 0.7×	2.4k 0.7×	201	12.4k
Bruce A.J. Ponder United Kingdom	65	8.2k 1.0×	2.3k 0.4×	5.1k 0.8×	3.5k 0.7×	1.7k 0.5×	180	15.7k
Lauri A. Aaltonen Finland	75	8.3k 1.0×	6.5k 1.0×	3.2k 0.5×	10.0k 1.9×	12.3k 3.5×	284	22.9k
Richard S. Houlston United Kingdom	68	8.5k 1.0×	3.7k 0.6×	4.5k 0.7×	6.4k 1.2×	7.0k 2.0×	468	20.2k
Ian Tomlinson United Kingdom	78	9.8k 1.2×	6.4k 1.0×	3.7k 0.6×	7.8k 1.5×	7.8k 2.2×	349	20.9k
Marco A. Pierotti Italy	85	13.3k 1.6×	5.5k 0.8×	3.8k 0.6×	10.7k 2.1×	3.9k 1.1×	457	27.2k
Katherine L. Nathanson United States	69	8.4k 1.0×	3.7k 0.6×	4.3k 0.7×	4.8k 0.9×	1.6k 0.5×	274	16.1k
Alan Ashworth United Kingdom	68	9.3k 1.1×	4.4k 0.7×	3.6k 0.6×	5.7k 1.1×	1.8k 0.5×	162	15.8k
Yusuke Nakamura Japan	82	15.2k 1.9×	5.4k 0.8×	3.6k 0.6×	8.0k 1.5×	4.8k 1.4×	377	25.6k
Ivan Bièche France	76	11.1k 1.4×	5.7k 0.9×	2.7k 0.4×	5.9k 1.1×	1.7k 0.5×	497	20.2k

Countries citing papers authored by Peter Devilee

Since Specialization

Citations

This map shows the geographic impact of Peter Devilee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Devilee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Devilee more than expected).

Fields of papers citing papers by Peter Devilee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Devilee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Devilee. The network helps show where Peter Devilee may publish in the future.

Co-authorship network of co-authors of Peter Devilee

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Devilee. A scholar is included among the top collaborators of Peter Devilee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Devilee. Peter Devilee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bueno‐Martínez, Elena, Pedro Pérez‐Segura, Mar Infante, et al.. (2023). Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants. Clinical Chemistry. 70(1). 319–338. 5 indexed citations

Fan, Chuannan, Qian Wang, Davy Cats, et al.. (2023). LncRNA LITATS1 suppresses TGF‐β‐induced EMT and cancer cell plasticity by potentiating TβRI degradation. The EMBO Journal. 42(10). e112806–e112806. 48 indexed citations

Brédart, Anne, Antoine De Pauw, Amélie Anota, et al.. (2022). Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study. Clinical Genetics. 102(1). 30–39. 2 indexed citations

Brédart, Anne, Jean‐Luc Kop, Antoine De Pauw, et al.. (2022). Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study. European Journal of Human Genetics. 30(9). 1067–1075. 6 indexed citations

Huang, Yongsheng, Sijia Liu, Wilma E. Mesker, et al.. (2022). RNF12 is regulated by AKT phosphorylation and promotes TGF-β driven breast cancer metastasis. Cell Death and Disease. 13(1). 44–44. 17 indexed citations

Boonen, Rick A.C.M., Wouter W. Wiegant, Bas Vroling, et al.. (2021). Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk. Cancer Research. 82(4). 615–631. 33 indexed citations

Buffet, Alexandre, Heggert Rebel, Eleonora P.M. Corssmit, et al.. (2020). Germline DLST Variants Promote Epigenetic Modifications in Pheochromocytoma-Paraganglioma. The Journal of Clinical Endocrinology & Metabolism. 106(2). 459–471. 8 indexed citations

Heemskerk‐Gerritsen, Bernadette A. M., Agnes Jager, Linetta B. Koppert, et al.. (2019). Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 177(3). 723–733. 114 indexed citations

Brédart, Anne, Amélie Anota, Alejandra Cano, et al.. (2019). The “Psychosocial Aspects in Hereditary Cancer” questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French‐, German‐ and Spanish‐language versions. European Journal of Cancer Care. 29(1). e13173–e13173. 3 indexed citations

10.

Brédart, Anne, Jean‐Luc Kop, Alejandra Cano, et al.. (2019). Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study. BMJ Open. 9(9). e029926–e029926. 9 indexed citations

11.

Hout, Annemieke van der, Jan C. Oosterwijk, Janet R. Vos, et al.. (2018). The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?. European Journal of Human Genetics. 26(6). 848–857. 6 indexed citations

12.

Robanus-Maandag, Els C., Cathy A.J. Bosch, Saeid Amini‐Nik, et al.. (2011). Familial Adenomatous Polyposis-Associated Desmoids Display Significantly More Genetic Changes than Sporadic Desmoids. PLoS ONE. 6(9). e24354–e24354. 22 indexed citations

13.

Hao, Huai‐Xiang, Oleh Khalimonchuk, Margit Schraders, et al.. (2009). SDH5 , a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma. Science. 325(5944). 1139–1142. 541 indexed citations breakdown →

14.

Middeldorp, Anneke, Shantie Jagmohan–Changur, Ronald van Eijk, et al.. (2009). Enrichment of Low Penetrance Susceptibility Loci in a Dutch Familial Colorectal Cancer Cohort. Cancer Epidemiology Biomarkers & Prevention. 18(11). 3062–3067. 53 indexed citations

15.

Hoya, Miguel de la, Hanne Meijers‐Heijboer, Juan Manuel Fernández, et al.. (2004). Mutant BRCA1 alleles transmission: Different approaches and different biases. International Journal of Cancer. 113(1). 166–167.

16.

Tavassoli, Fattaneh A. & Peter Devilee. (2003). Pathology and Genetics of Tumours of the Breast and Female Genital Organs. 2215 indexed citations breakdown →

17.

Hoya, Miguel de la, Ana Osório, Alicia Tosar, et al.. (2001). Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing. International Journal of Cancer. 97(4). 466–471. 62 indexed citations

18.

Devilee, Peter, et al.. (2000). [From gene to disease; from BRCA1 or BRCA2 to breast cancer].. PubMed. 144(53). 2549–51. 3 indexed citations

19.

Verhoog, L.C., et al.. (1999). Prophylactic surgery in BRCA1/2 mutation carriers Predictive factors and follow-up. The American Journal of Human Genetics. 65(4). 22. 3 indexed citations

20.

Vijver, Marc J. van de, et al.. (1987). Amplification of the neu (c- erbB-2 ) Oncogene in Human Mammmary Tumors is Relatively Frequent and is Often Accompanied by Amplification of the Linked c- erbA Oncogene. Molecular and Cellular Biology. 7(5). 2019–2023. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact